Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2018-11-26 | Shmuel (Samuel) Rubinstein became a director of the Company effective May 29, 2018. ... The current members of our Audit Committee are David Gill (Chair), Samuel Rubinstein, and LuAnn Via. ... The current members of our Compensation/Nominating Corporate Governance Committee are Nachum Shamir (Chair), David Gill, and Samuel Rubinstein. |
| 2019-11-27 | Samuel Rubinstein became a director of the Company effective May 29, 2018. ... The table below sets forth our non-employee directors compensation for the year ended December 31, 2018. Samuel Rubinstein Fees Earned ($) 24,583, Stock Awards ($) 55,000, Total ($) 79,583. |
| 2020-11-27 | Samuel Rubinstein ... services on the Audit Committee and on the Compensation/Nominating and Governance Committee. ... Director compensation $80,000. |
| 2021-06-02 | Shmuel (Samuel) Rubinstein became a director of the Company effective May 29, 2018. ... The table below provides membership information for each of these committees: ... Samuel Rubinstein serves on Audit Committee and Compensation/Nominating and Governance Committee. ... The table below sets forth our non-employee directors’ compensation for the year ended December 31, 2020. ... Samuel Rubinstein received $45,000 in fees. |
| 2022-05-18 | Shmuel (Samuel) Rubinstein became a director of the Company effective May 29, 2018. ... The current members of our Audit Committee are Douglas Strang (Chair), Samuel Rubinstein, and Patricia Walker, each of whom we believe satisfies the independence requirements of NASDAQ and the SEC. ... The current members of our Compensation and Nominating/Governance Committee are Nachum Shamir (Chair), Samuel Rubinstein, and William Humphries each of whom we believe satisfies the independence requirements of NASDAQ. ... DIRECTOR COMPENSATION TABLE ... Samuel Rubinstein Fees Earned 45,000 Stock Awards 36,511 Total 81,511. |
| 2023-09-25 | Shmuel (Samuel) Rubinstein became a director of the Company effective May 29, 2018. Mr. Rubinstein years of experience in the pharmaceutical and medical device fields include having served for over 20 years as the Chief Executive Officer and General Manager of Taro Pharmaceuticals Industries, overseeing its successful acquisition by SUN Pharma.. ... Mr. Rubinstein serves as a board member on the boards of Mediwound Ltd., Medison Biotech, Trima Pharma (where he serves as chairman), and KSDG. ... We believe Mr. Rubinstein's qualifications to serve on the Board of Directors include his wealth of knowledge and industry expertise in finance, investment banking, mergers and acquisitions, equity research and investment management experience in the dermatology industry. ... Audit Committee: ... Samuel Rubinstein ... Compensation and Nominating/Governance Committee: ... Samuel Rubinstein ... Director Compensation Table: ... Samuel Rubinstein $80,000 total compensation. |
Data sourced from SEC filings. Last updated: 2026-03-05